Pembrolizumab for the Treatment of Relapsed or Refractory Multiple Myeloma After Anti-BCMA CAR-T Therapies
Clinical trial NCT05191472 · TERMINATED
Trial details
- NCT number
- NCT05191472
- Sponsor
- Alfred Chung, MD
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-03
- Primary completion
- 2023-12-31
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.